Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury.
Gerhardt W, Nordin G, Herbert AK, Burzell BL, Isaksson A, Gustavsson E, Haglund S, Müller-Bardorff M, Katus HA
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of collection tube type and heparin dose on plasma and serum levels of cardiac troponin T (cTnT) and troponin I (TnI) in patients at different stages of MI.
Summary of Findings
The plasma to serum cTnT ratio was found to be unaffected by collection tube type; however addition of increasing quantities of heparin to serum caused a highly variable decrease in cTnT and Tn1 levels. The largest losses were found in specimens from patients in early MI stages or in specimens collected within the first 12 h after onset of chest pain. In contrast, the smallest losses occurred in specimens from patients in late MI stages or in specimens collected 48 h after onset of chest pain. The cTnT ratio was found to decline with increasing creatine kinase MB isoenzyme (CKMB) mass.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)Diagnoses
Cardiovascular DiseasePlatforms
ProteinImmunoassayProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Early MILate MIBiospecimen Acquisition Anticoagulant Lithium heparinNoneSodium heparinBiospecimen Acquisition Time of biospecimen collection 1-12 h after onset of chest pain13-48 h after onset of chest painMore than 48 h after onset of chest painBiospecimen Acquisition Type of collection container/solution BD PET PSTBD PET PST with gelBD SSTBD glass PSTBD glass PST with gelGreiner VacuetteTerumo Venoject SSTBiospecimen Aliquots and Components Biospecimen components 450 IU/mL Heparin50 IU/mL Heparin98 IU/mL HeparinBiospecimen Aliquots and Components Blood and blood products PlasmaSerum